Thursday, 27 January 2022

Australia's most trusted
source of pharma news

Thursday, 27 January 2022

Yes, meds sovereignty is a race

Posted 9 December 2021 AM

Medicines Australia has told the Senate inquiry into manufacturing that the pandemic has caused countries around the world to reassess the importance of the life sciences industry, and the race is on to secure national sovereignty of medications.

"One thing that is obvious is that right now there is a global recalibration," Independent Chair of Medicines Australia, Dr Anna Lavelle, told the inquiry. "The pandemic has raised these questions in many countries, and there are many conversations taking place all around the world around sovereign risk mitigation and about recalibration in the life science area."

To see the whole article, please login

Email this article to a friend

Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.


Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.


Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).


You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.


You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.